Repeated switches between reference product etanercept and biosimilar do not affect disease activity or retention rate of etanercept over 24 months – a cohort study with historical controls

Publication date: Available online 22 December 2018Source: Joint Bone SpineAuthor(s): Valgerdur Sigurdardottir, Anna Svärd
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research